Despite the diverse and potent bioactivities displayed
by axially
chiral biaryl natural products, their application in drug discovery
is limited by restricted access to these complex molecular scaffolds.
In particular, fundamental challenges remain in controlling the site-
and atroposelectivity in biaryl coupling reactions. In contrast, Nature
has a wealth of biosynthetic enzymes that catalyze biaryl coupling
reactions with catalyst-controlled selectivity. In particular, a growing
subset of fungal P450s have been identified to catalyze site- and
atroposelective biaryl couplings. Herein, we optimize a whole-cell
biocatalytic platform in Pichia pastoris to synthesize
biaryl molecules through the recombinant production of the fungal
P450 KtnC. Moreover, engineering redox self-sufficient fusion enzymes
further improves the efficiency of the system. Altogether, this work
provides a platform for biaryl coupling reactions in yeast that can
be applied to engineering a currently underexplored pool of fungal
P450s into selective biocatalysts for the synthesis of complex biaryl
compounds.